Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response - Concepedia

Concepedia

Publication | Open Access

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response

DOI Full Paper Access

40

Citations

38

References

2014

Year

Kian Bichoupan, Valérie Martel‐Laferrière, David Sachs, Michel Ng, Emily Schonfeld, Alexis Pappas, James F. Crismale, Alicia Stivala, Viktoriya Khaitova, Donald Gardenier,

Abstract

TVR and Peg-IFN accounted for 85% of costs. Pharmaceutical prices and the low (44%) SVR rate, in this real-world study, were major contributors to the high cost per SVR.

References

	Year	Citations

Page 1